Neuroendocrine Carcinomas of the Uterine Cervix:
A Clinicopathological Study
Panitta Sitthinamsuwan MD*, Napat Angkathunyakul MD*,
Tuenjai Chuangsuwanich MD*, Perapong Inthasorn MD**
Affiliation :
* Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
** Department of Obstetrics Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Background : Neuroendocrine carcinoma (NEC) is a rare entity of uterine cervical carcinoma. Most of them have a more
aggressive course and worse prognosis than a common type squamous cell carcinoma. Therefore, precise diagnosis is very
crucial.
Objective : To study clinicopathological correlation and immunohistochemistry of uterine cervical NEC
Material and Method: All primary uterine cervical carcinomas from a 51-month period were histopathologically reviewed.
Suspicious NECs were retrieved and immunohistochemically studied for chromogranin, synaptophysin, non-specific esterase
(NSE) and CD56. Clinical information including treatments and mean disease free survival time were obtained from chart
review.
Results : Fourteen (3.5%) cases of NEC were identified from 389 primary uterine cervical carcinomas between October 1,
2002 and December 31, 2006 and classified into small cell neuroendocrine carcinoma (SNEC, 8 cases), large cell
neuroendocrine carcinoma (LNEC, 3 cases), mixed SNEC and adenocarcinoma (2 cases), and mixed SNEC and squamous
cell carcinoma (1 case). All NEC presented with abnormal vaginal bleeding. The median age was 44 years (34-75 years).
Exophytic mass was noted in 11 patients (78.6%). Five patients (36%) had distant metastases. All cases were immunoreactive
for at least two neuroendocrine markers. Nine cases (64.3%) were positive for chromogranin, 11 (78.6%) for synaptophysin,
12 (85.7%) for NSE, and 11 (78.6%) for CD56. CD56 was positive in eight of 11 SNEC cases. The mean disease free interval
and overall survival time were 17.5 and 23.9 months, respectively.
Conclusion : Neuroendocrine carcinoma of the cervix is rare and has poor prognosis. In addition to histopathology, panel
of immunohistochemistry is mandatory in the diagnosis of neuroendocrine carcinoma. Varying results of immunohistochemistry
may be found.
Keywords : Neuroendocrine carcinoma, Cervical carcinoma, Small cell carcinoma, CD56
All Articles
Download